|1.||Bradford, Williamson Z: 3 articles (07/2009 - 01/2004)|
|2.||Antoniou, Katerina M: 3 articles (12/2008 - 06/2004)|
|3.||Siafakas, Nikolaos M: 3 articles (12/2008 - 06/2004)|
|4.||King, Talmadge E: 2 articles (07/2009 - 01/2004)|
|5.||Noble, Paul W: 2 articles (07/2009 - 01/2004)|
|6.||Tzortzaki, Eleni G: 2 articles (12/2008 - 06/2004)|
|7.||Mojtahedzadeh, Mojtaba: 2 articles (01/2006 - 06/2005)|
|8.||Ghanei, Mostafa: 2 articles (01/2006 - 06/2005)|
|9.||Aslani, Jafar: 2 articles (01/2006 - 06/2005)|
|10.||Hsu, Henry H: 2 articles (07/2005 - 06/2004)|
|1.||Renal Cell Carcinoma (Grawitz Tumor)
03/01/1987 - "Our results suggest that treatment with anticancer drugs in combination with recombinant gamma-interferon is effective for renal cell carcinoma."
06/01/1990 - "The efficacy of a low-dose regimen of human recombinant interferon-gamma was studied in 40 patients with metastatic or locally advanced renal cell carcinoma. "
10/01/2000 - "Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. "
05/01/1998 - "Activity has been reported in phase II single-center, open-label studies after administration of low-dose recombinant interferon gamma-1b (rIFN-gamma) to patients with metastatic renal cell carcinoma, with an overall objective response proportion of around 15%. "
01/01/1995 - "[A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes]."
08/01/2014 - "Therefore, an attempt was made to evaluate the effect of live (sub-lethal) and inactivated (antigenic form) N. seriolae on cellular and humoral immunity in ginbuna crucian carp, Carassius auratus langsdorfii as well as the therapeutic potency of recombinant interferon gamma (rIFN γ) against N. seriolae infection. "
01/01/2009 - "Despite recombinant interferon-gamma prophylaxis, invasive filamentous fungal infections are a persistent problem in CGD. "
02/15/2001 - "Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. "
01/01/1997 - "The effect of recombinant interferon-gamma (rIFN-gamma) on Leishmania infantum infection was investigated in vivo. "
07/01/1995 - "Treatment of the cells with ovine recombinant interferon gamma for 24 h before infection significantly inhibited intracellular multiplication of the parasite."
|3.||Atopic Dermatitis (Atopic Eczema)
02/01/1993 - "Previous open trials have suggested efficacy for recombinant interferon-gamma (rIFN-gamma) in treatment of severe atopic dermatitis. "
01/01/2002 - "Initial open-label studies, a double-blind placebo trial, and long-term open-label studies have demonstrated the clinical efficacy and tolerability of recombinant interferon-gamma in a subset of patients with severe, unremitting atopic dermatitis. "
01/01/2002 - "These immunological findings led to a number of clinical trials with recombinant interferon-gamma in patients who had severe, unremitting atopic dermatitis. "
01/01/2002 - "Although the exact mechanism by which recombinant interferon-gamma brings about clinical changes in patients with atopic dermatitis is unknown, recombinant interferon-gamma should be considered a possible therapy for patients with atopic dermatitis."
01/01/2002 - "Atopic dermatitis: the role of recombinant interferon-gamma therapy."
01/01/2006 - "The purpose of this research was to evaluate the efficacy of interferon gamma-1b on the lung function in MG exposed patients with bronchiolitis. "
06/01/2005 - " purpose of this research was to evaluate the efficacy of interferon gamma-1b on the lung function in mustard gas exposed patients with bronchiolitis. "
01/01/2006 - "The findings of this study indicate that a 6-month treatment with interferon gamma-1b plus a low-dose prednisolone is associated with an improvement in the lung function in mustard-gas exposed patients with bronchiolitis."
04/10/1997 - "This study was designed to determine the effector molecule responsible for the tumor-inhibitory activity of rat neutrophils treated with rat recombinant interferon gamma (rIFN-gamma) in vitro. "
10/31/1994 - "The purpose of the present study was to investigate whether human recombinant interferon-gamma (hrIFN-gamma) can act synergically with various activators in increasing the cytotoxicity of cancer patient monocytes against fresh autologous and allogeneic tumor cells. "
09/01/1990 - "Recombinant interferon-gamma (rIFN-gamma) is currently undergoing clinical trials in cancer patients. "
01/01/1990 - "A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients."
08/01/1989 - "The object of this study was to investigate the effects of different single doses of recombinant interferon-gamma (rIFN-gamma) on white blood cell counts, differential blood counts, and the relative composition of T-cell subsets in the peripheral blood of cancer patients. "
|1.||Interferon-gamma (Interferon, gamma)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||Mustard Gas (Sulfur Mustard)
|6.||Immunoglobulin E (IgE)
|9.||Medroxyprogesterone Acetate (Depo-Provera)
|1.||Drug Therapy (Chemotherapy)